Industry: Atrificial Vectors and Immune Cells
Headquarters: San Francisco, California, United States
Founded Date: 2015-01-01
Funding Status: IPO
Investors Number: 20
Total Funding: 234900000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-02-11
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership